Deciphera Financial Statements From 2010 to 2025

Deciphera Pharmaceuticals financial statements provide useful quarterly and yearly information to potential Deciphera Pharmaceuticals LLC investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Deciphera Pharmaceuticals financial statements helps investors assess Deciphera Pharmaceuticals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Deciphera Pharmaceuticals' valuation are summarized below:
Deciphera Pharmaceuticals LLC does not presently have any fundamental signals for analysis.
Check Deciphera Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Deciphera Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Deciphera financial statements analysis is a perfect complement when working with Deciphera Pharmaceuticals Valuation or Volatility modules.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Deciphera Pharmaceuticals LLC Company Operating Margin Analysis

Deciphera Pharmaceuticals' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Deciphera Pharmaceuticals Operating Margin

    
  (1.09) %  
Most of Deciphera Pharmaceuticals' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Deciphera Pharmaceuticals LLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Deciphera Pharmaceuticals LLC has an Operating Margin of -1.0855%. This is 96.91% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The operating margin for all United States stocks is 80.3% lower than that of the firm.

Deciphera Pharmaceuticals Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Deciphera Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Deciphera Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Deciphera Pharmaceuticals competition to find correlations between indicators driving Deciphera Pharmaceuticals's intrinsic value. More Info.
Deciphera Pharmaceuticals LLC is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Deciphera Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Currently Active Assets on Macroaxis

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in Deciphera Stock

If you are still planning to invest in Deciphera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deciphera Pharmaceuticals' history and understand the potential risks before investing.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated